Amphastar Pharmaceuticals Statistics
Total Valuation
AMPH has a market cap or net worth of $918.82 million. The enterprise value is $1.32 billion.
| Market Cap | 918.82M |
| Enterprise Value | 1.32B |
Important Dates
The last earnings date was Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AMPH has 42.54 million shares outstanding. The number of shares has decreased by -7.79% in one year.
| Current Share Class | 42.54M |
| Shares Outstanding | 42.54M |
| Shares Change (YoY) | -7.79% |
| Shares Change (QoQ) | -4.81% |
| Owned by Insiders (%) | 10.38% |
| Owned by Institutions (%) | 67.75% |
| Float | 31.29M |
Valuation Ratios
The trailing PE ratio is 12.80 and the forward PE ratio is 6.79.
| PE Ratio | 12.80 |
| Forward PE | 6.79 |
| PS Ratio | 1.26 |
| Forward PS | 1.19 |
| PB Ratio | 1.20 |
| P/TBV Ratio | 7.64 |
| P/FCF Ratio | 6.01 |
| P/OCF Ratio | 4.98 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.77, with an EV/FCF ratio of 8.61.
| EV / Earnings | 16.77 |
| EV / Sales | 1.80 |
| EV / EBITDA | 6.77 |
| EV / EBIT | 9.59 |
| EV / FCF | 8.61 |
Financial Position
The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.90.
| Current Ratio | 2.40 |
| Quick Ratio | 1.66 |
| Debt / Equity | 0.90 |
| Debt / EBITDA | 3.33 |
| Debt / FCF | 4.50 |
| Interest Coverage | 6.32 |
Financial Efficiency
Return on equity (ROE) is 10.30% and return on invested capital (ROIC) is 9.06%.
| Return on Equity (ROE) | 10.30% |
| Return on Assets (ROA) | 5.11% |
| Return on Invested Capital (ROIC) | 9.06% |
| Return on Capital Employed (ROCE) | 9.28% |
| Weighted Average Cost of Capital (WACC) | 6.30% |
| Revenue Per Employee | $369,443 |
| Profits Per Employee | $39,751 |
| Employee Count | 1,976 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.06 |
Taxes
In the past 12 months, AMPH has paid $23.48 million in taxes.
| Income Tax | 23.48M |
| Effective Tax Rate | 23.01% |
Stock Price Statistics
The stock price has decreased by -27.08% in the last 52 weeks. The beta is 0.90, so AMPH's price volatility has been similar to the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | -27.08% |
| 50-Day Moving Average | 20.01 |
| 200-Day Moving Average | 22.68 |
| Relative Strength Index (RSI) | 62.12 |
| Average Volume (20 Days) | 441,165 |
Short Selling Information
The latest short interest is 4.93 million, so 11.59% of the outstanding shares have been sold short.
| Short Interest | 4.93M |
| Short Previous Month | 4.17M |
| Short % of Shares Out | 11.59% |
| Short % of Float | 15.75% |
| Short Ratio (days to cover) | 12.30 |
Income Statement
In the last 12 months, AMPH had revenue of $730.02 million and earned $78.55 million in profits. Earnings per share was $1.69.
| Revenue | 730.02M |
| Gross Profit | 348.11M |
| Operating Income | 137.39M |
| Pretax Income | 102.02M |
| Net Income | 78.55M |
| EBITDA | 194.51M |
| EBIT | 137.39M |
| Earnings Per Share (EPS) | $1.69 |
Balance Sheet
The company has $290.12 million in cash and $688.32 million in debt, with a net cash position of -$398.20 million or -$9.36 per share.
| Cash & Cash Equivalents | 290.12M |
| Total Debt | 688.32M |
| Net Cash | -398.20M |
| Net Cash Per Share | -$9.36 |
| Equity (Book Value) | 768.16M |
| Book Value Per Share | 18.06 |
| Working Capital | 367.75M |
Cash Flow
In the last 12 months, operating cash flow was $184.61 million and capital expenditures -$31.72 million, giving a free cash flow of $152.89 million.
| Operating Cash Flow | 184.61M |
| Capital Expenditures | -31.72M |
| Depreciation & Amortization | 57.13M |
| Net Borrowing | -257,000 |
| Free Cash Flow | 152.89M |
| FCF Per Share | $3.59 |
Margins
Gross margin is 47.68%, with operating and profit margins of 18.82% and 10.76%.
| Gross Margin | 47.68% |
| Operating Margin | 18.82% |
| Pretax Margin | 13.98% |
| Profit Margin | 10.76% |
| EBITDA Margin | 26.65% |
| EBIT Margin | 18.82% |
| FCF Margin | 20.94% |
Dividends & Yields
AMPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.79% |
| Shareholder Yield | n/a |
| Earnings Yield | 8.55% |
| FCF Yield | 16.64% |
Analyst Forecast
The average price target for AMPH is $22.50, which is 4.17% higher than the current price. The consensus rating is "Hold".
| Price Target | $22.50 |
| Price Target Difference | 4.17% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 3.93% |
| EPS Growth Forecast (3Y) | 1.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AMPH has an Altman Z-Score of 2.18 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.18 |
| Piotroski F-Score | 4 |